Comprehensive Study Notes from Transcription (Medical/Reproductive Health and Related Care)

Safety, Reporting, and Professional Responsibilities

  • Impaired coworkers: do not confront them directly; report to the supervisor. If there is an incline or suspicion, you should report rather than engage in confrontation.
  • Mandatory reporting: as reporters, you are mandatory reporters.
  • Good Samaritan protection: if you decide to help, you are protected by Good Samaritan laws.
  • Reportable diseases: all hepatitis, COVID, cancer, HIV, and syphilis are reportable diseases.
  • Specimen collection roles:
    • When collecting sputum, the LVN may perform collection.
    • CNAs can perform specimen collection only and not the evaluation/interpretation side.
  • Privacy: stop staff from discussing patients’ personal details.
  • Prioritization framework (Maslow and nursing process):
    • Priority: POSITION—correct the patient’s position, as proper positioning can dramatically improve outcomes.
    • ABCs: Airway, Breathing, Circulation (safety first).
    • Maslow’s hierarchy: Physiological needs are always first.
    • ADPI: Assess First; differentiate acute vs chronic; unexpected vs expected.
  • Goals of care: SMART goals:
    SMART=Specific,Measurable,Attainable,Realistic,Time-bound\text{SMART} = {\text{Specific}, \text{Measurable}, \text{Attainable}, \text{Realistic}, \text{Time-bound}}
  • Reproductive system: Invasive procedures require a doctor to perform the procedure (not the nurse), with the exception noted as “EXCEPT PIC IV”. Nurses serve as witnesses to informed consent.
  • Informed consent principles:
    • Informed consent is permission given with understanding of risks, benefits, and alternatives (including doing nothing).
    • Nurses generally obtain verbal or implied consent (e.g., movement of arm) for procedures; physicians require informed consent.
    • If a patient does not want a procedure, ask about their concerns to address objections and seek alternatives.

Informed Consent and Procedures in Reproductive Health

  • Pelvic exams: Begin at age 21.
    • Age-based screening intervals for Pap smears:
    • Age 21–29: every 3 years (unless abnormal findings).
    • Age 30–65: every 5 years (often with HPV testing; follow local guidelines).
    • After age 65: typically stop routine screening if previous tests were normal.
  • Pap smear purpose: to check for precancerous and cancerous cells in the cervix; may involve a cervical brush or sampling device.
  • First screening timing: begins at age 21; prior consent required.
  • Pre-procedure instructions for Pap smear:
    • Void before the exam.
    • Schedule 6–10 days after the last menstrual period.
  • Intra-procedure notes:
    • The patient should be in lithotomy position.
    • Lubricant used; deep breaths; relax muscles; insert brush for sampling.
  • Post-procedure expectations:
    • Provide perineal tissues; avoid sexual intercourse and vaginal douching for 24 hours.
    • If abnormal results, ultrasound may be requested.
    • If latex allergy is present, inform provider.
    • Abdominal ultrasound may require a full bladder; a void is usually advised first.
  • Biopsy considerations:
    • If a biopsy is planned, informed consent is required.
    • If abnormal cells are found, a colposcopy with light and camera is typically performed to examine the region in more detail.
    • Best to perform screening early in the menstrual cycle to help discern cancerous changes.
  • Post-procedure restrictions:
    • No insertion for the first 24–48 hours after certain procedures; rest for 2 days (per transcript specifics).

Gynecologic Procedures: Post-Procedure Care and Surgeries

  • Post-procedural care after gynecologic procedures:
    • Do not insert anything into the vagina for the first 24–48 hours after certain procedures; rest for 24 hours.
  • After endometrial biopsy:
    • Empty bladder prior to procedure.
    • Apply perineal pad for heavy bleeding.
  • Hysterectomy overview:
    • Approaches: abdominal, vaginal, or laparoscopic with contrast dye.
    • It is a common gynecologic procedure (second most common after some other gynecologic procedures mentioned).
    • Potential complications: hypovolemic shock, infection, psychological issues.
    • Types:
    • Total hysterectomy: remove uterus and cervix.
    • Partial/supracervical hysterectomy: uterus removed but cervix retained.
    • Radical hysterectomy (not described as standard here): uterus and cervix with upper vagina removal (for certain cancers).
    • Salpingo-oophorectomy: removal of one or both ovaries and fallopian tubes.
  • Perioperative considerations:
    • Do not perform pregnancy tests too late; ensure patient is not pregnant prior to some procedures.
    • Avoid anticoagulants when not indicated; assess bleeding risk.
    • Encourage ambulation as soon as possible to reduce DVT risk.
    • Before surgery, obtain informed consent.
    • Monitor pain frequently; provide antibiotics and IV fluids as indicated.
    • If bowel sounds and gag reflex return, oral intake (food) may resume.
  • Postoperative bleeding and wound care:
    • Monitor vaginal bleeding; excessive bleeding is defined as more than 1 saturated pad in 1 hour.
    • No baths after procedures due to infection risk.
  • Menopause and pregnancy considerations:
    • Ovaries removed -> menopause will occur; advise on subsequent management.
  • Mammography basics (brief):
    • Avoid deodorant or lotion in breast area prior to the exam.
    • Mammograms are used with imaging to detect lesions; screening recommendations include age-based guidelines (see Section on Breast Imaging).

Breast Imaging and HIV/Syphilis Screening

  • Mammography details:
    • Breast imaging uses two views (vertical and horizontal) to reveal abnormalities.
    • The breast is compressed vertically during the exam.
    • Age-based screening recommendations:
    • 40–44 years: optional annual screening.
    • >55 years: switch to screening every other year (biennial).
    • Diagnostic mammography is used to reveal abnormal findings.
    • Do not apply deodorant or lotion to axillary or breast area as it may interfere with results.
    • Provide privacy; explain mild discomfort during compression; respect patient privacy during dress/undress.
  • HIV testing and management:
    • HIV screening can involve blood, saliva, immunology, and virology testing to identify RNA presence.
    • Screening protocol typically requires two ELISA/EIA tests; confirm with Western Blot if positive.
    • HIV has no cure; management focuses on monitoring and treatment.
    • Rapid HIV testing (OraQuick) is available as a quick screening method.
  • Syphilis screening and confirmation:
    • Screening: RPR or VDRL (non-treponemal tests).
    • Confirmation: FTA-ABS (treponemal antibody test).
  • General sexual health assessment:
    • Five Ps framework for obtaining sexual history:
    • P1: Partners
    • P2: Practices (type of sexual activity)
    • P3: Protection (use of condoms, barriers)
    • P4: Past history
    • P5: Prevention of pregnancy and STIs
  • Herpes management:
    • Acyclovir is a common antiviral noted for management.

Sexually Transmitted Infections: Overview and Treatments

  • Syphilis:
    • Treatment options: Penicillin (preferred) or doxycycline if allergic.
    • Clinical stages include primary chancre, secondary stage with rash and lymphadenopathy, possible meningitis, and late stage with systemic effects (years later: dementia, neurologic involvement).
  • Bacterial vaginosis:
    • Presentation: white/grey milky discharge with fishy odor.
    • Treatments: Metronidazole or Clindamycin.
    • Metronidazole notes: avoid alcohol due to disulfiram-like reaction; take probiotics to restore flora.
  • Candidiasis (yeast infection):
    • Presentation: white, clumpy discharge (curd-like).
    • Treatments: topical miconazole or systemic fluconazole; ketoconazole or nystatin for vaginal candidiasis.
  • Gonorrhea:
    • Common STI; symptoms may be asymptomatic in females.
    • Transmission: genital-to-genital or anal contact.
  • Trichomoniasis:
    • Presentation: frothy, yellow-green discharge; itching; can spread male-to-female or female-to-female.
  • Prophylaxis and maternal-fetal considerations:
    • Infections in pregnancy can affect birth weight and neonatal outcomes; treat accordingly.
    • Penicillin remains a key treatment for certain infections during pregnancy when indicated.
  • Gestational and sexual health details:
    • Dual therapy can be used for gonorrhea and chlamydia co-infection (example: azithromycin plus another antibiotic such as ceftriaxone).
  • Neonatal prophylaxis:
    • Eye prophylaxis for babies at birth to prevent neonatal blindness due to gonorrhea exposure.

Menstrual Health, Menopause, and Related Conditions

  • Menstrual cycle basics:
    • Follicular phase: first 14 days of a 28-day cycle.
    • Luteal phase: second half of the cycle.
  • Menarche and menopause:
    • Average age of menarche ~12.4 years (range ~10–16).
    • Menopause typically begins around age 51; transition may start earlier with perimenopause.
    • Perimenopause is a transition period (~4 years before menopause) with irregular periods and vasomotor symptoms.
    • Postmenopause: about 1 year after cessation of menses; symptoms include hot flashes, vaginal dryness (atrophic vaginitis), decreased bone density, decreased skin elasticity, headaches.
  • Common menstrual disorders:
    • Dysmenorrhea: painful periods (often reported as severe cramps).
    • Amenorrhea: absence of menses (pregnancy or thyroid issues can be causes).
    • Oligomenorrhea: infrequent periods.
    • Menorrhagia: heavy menstrual bleeding with clots; may saturate more than one pad per hour.
  • Hormonal therapy:
    • Used to manage menopausal symptoms.
    • Fiber and whole grain intake recommended; weight-bearing exercises advised to maintain bone density.
  • Peri-/post-menopause risk factors and management:
    • Lifestyle strategies to mitigate symptoms and maintain health.
  • Note on terminology:
    • Some terms in the source text (e.g., “cyctosal(y)” as a menopause risk factor) are unclear; typical risk factors include age, genetics, lifestyle, and comorbidities.
  • Pelvic floor health:
    • Kegals (pelvic floor exercises) help manage pelvic floor weakness and urinary symptoms.
  • Constipation as a risk factor for rectosigmoid issues; prolonged sitting weakens rectal muscles.

Male Reproductive Health: Testes, Prostate, and Related Examinations

  • Infections and anatomy:
    • STI infection risk is high; keep hygiene and protective practices in mind.
    • Seminal fluid origins:
    • Seminal vesicles contribute around ~60% of semen.
    • Prostate gland secretes alkaline fluid that supports sperm motility.
    • Cowper (bulbourethral) glands provide lubrication during intercourse.
    • Sperm anatomy: head, midpiece, and tail.
    • Sperm fertilization: once the sperm enters the ovum, fertilization is complete with no additional sperm entering.
  • Undescended testes (cryptorchidism):
    • If testes do not descend into the scrotum prenatally, they remain in the abdomen.
    • Risk: high risk for infertility and testicular cancer.
  • Testicular self-exam:
    • Recommended monthly self-exams for males aged 15–39.
    • If you notice a lump, seek further evaluation from a clinician.
  • Acute scrotal conditions:
    • Acute hydrocele: accumulation of fluid in the tunica vaginalis; testicular swelling may occur.
    • Management: elevate the scrotum, bed rest, ice 10–20 minutes; monitor closely.
    • Do not ignore severe pain or signs of compromised circulation.
  • Erectile function and health: overview of normal vs impaired function.
  • Prostate health:
    • Digital rectal exam (DRE) and PSA testing used to screen for prostate issues.
    • Age guidelines: consider DRE/PSA at age ~40 for higher-risk individuals; typical screening around age 50 for average risk.
    • Informed consent required; position options include leaning over the table or side-lying (fetal) position; use of gloved, lubricated finger; prepare for potential ultrasound or biopsy if abnormalities found.
    • Possible transient urge to urinate during the exam.
  • PSA values and interpretation:
    • PSA levels: low 0–2.5, moderate 10–19, high 20+ (note: the transcript provides these ranges and emphasizes follow-up testing).
    • If PSA is elevated, additional testing such as EPCA (a related marker) may be considered; an elevated EPCA (> ~30) may indicate cancer in the context of other findings.
    • If abnormal labs, consider transrectal ultrasound to evaluate the prostate.
  • Anticoagulants and procedures:
    • Patients on anticoagulants should be assessed for bleeding risk; continuation or discontinuation depends on clinical judgment.
  • Counseling and consent:
    • Invasive prostate procedures require informed consent; assess risks, benefits, and alternatives.

Pharmacology, Erectile Dysfunction, and Benign Prostatic Hyperplasia (BPH)

  • Erectile Dysfunction (ED):
    • Etiologies: organic (vascular, neurogenic, hormonal) and psychological (stress, anxiety, depression).
    • Morning erections suggest a physiological integrity of the vascular system; absence may indicate psychogenic causes or other issues.
    • Treatment approaches include lifestyle modifications, pharmacologic agents, and psychological support.
  • Phosphodiesterase type 5 inhibitors (PDE5i):
    • Sildenafil (Viagra) is a common agent; contraindicated with nitrates and in certain cardiovascular conditions.
    • Common side effects: headaches; avoid grapefruit juice; abstain from alcohol while taking PDE5 inhibitors.
    • Etiology and interactions: no alcohol and no nitrates when taking PDE5 inhibitors.
  • BPH pharmacotherapy:
    • 5-Alpha-reductase inhibitors (e.g., Finasteride) reduce prostate size over approximately 6 months; side effects can include breast enlargement (gynecomastia) and decreased libido; may be teratogenic; avoid handling by pregnant people.
    • Alpha-1 blockers (e.g., Tamsulosin) relax bladder and prostatic smooth muscle; adverse effects include tachycardia and orthostatic hypotension; patients should change positions slowly.
  • Other medications:
    • 5-phosphodiesterase inhibitors and alpha blockers used in combination therapy for symptom relief; monitor interactions and patient tolerance.
  • TURP (transurethral resection of the prostate):
    • Surgical management for BPH; requires informed consent.
    • Postoperative management includes monitoring for persistent bright red bleeding and performing continuous bladder irrigation (CBI) with a catheter.
    • Patient experiences urge to urinate; avoid pushing; irrigation is ongoing during initial hours post-op.
    • Monitor urinary output, catheter patency, and clot formation; increase CBI rate if bright red bleeding persists; notify provider if clots cannot be dislodged.
    • Postoperative care also includes analgesia, antibiotics, and stool softeners to prevent straining.
  • Pelvic floor and supportive devices:
    • Pesary is a device used to hold cystocele in place.
  • General post-TURP considerations:
    • After catheter removal, monitor voiding and urinary function; counsel on activity restrictions and follow-up.

Diagnostic Procedures, Imaging, and Related Care

  • Colorectal and pelvic imaging:
    • Transrectal ultrasound (TRUS) is used to evaluate prostate abnormalities and guide biopsy.
  • Miscellaneous diagnostic tests:
    • Enema may be recommended one hour prior to certain procedures.
    • Latex allergy should be assessed prior to imaging or procedures requiring latex-containing equipment.
    • PSA and biopsy decisions require informed consent and careful patient education.

Key Definitions and Concepts to Remember

  • Informed consent: formal permission after understanding risks, benefits, and alternatives to a procedure.
  • Lithotomy position: a common position for gynecologic exams and procedures.
  • Colposcopy: magnified examination of the cervix with light and camera to assess abnormal areas after an abnormal Pap test.
  • Hysterectomy types: total (uterus + cervix) vs partial/supracervical; radical (uterus, cervix, and upper vagina) not detailed here.
  • DVT prevention strategies: ambulation and early mobilization after surgery.
  • Screening intervals by age (breast):
    • 40–44: optional annual screening
    • 55+: biennial (every other year)
  • Menopause terminology:
    • Perimenopause: transitional period before menopause with irregular cycles.
    • Postmenopause: period after cessation of menses for 12 months.

Quick Reference: Age-Based Screenings and Interventions

  • Pap smear: start at 21; intervals depend on age and guidelines (3 years for 21–29; 5 years for 30–65 with HPV testing as appropriate).
  • Mammography: start discussions at 40; annual option at 40–44; switch to biennial after age 55 if asymptomatic.
  • Prostate screening: discuss DRE/PSA starting around age 40 for higher risk; 50 for average risk; informed consent required.
  • STI screening: use ELISA/EIA testing with confirmatory tests as indicated; non-cure for HIV; treat bacterial infections appropriately; wariness around alcohol interactions with some medications.
  • Postoperative care and risk awareness for TURP and gynecologic surgeries: monitor bleeding, infection signs, pain management, and careful ambulation to reduce complications.

Notes on Ambiguities and Clarifications (from the transcript)

  • Some terms are misspelled or ambiguous (e.g., “CAPOSCAPY” likely Colposcopy; “ETC” may refer to other exam steps). When studying, cross-check with current clinical guidelines for exact terminology and protocols.
  • Some age ranges and treatment sequences in the transcript reflect general concepts but may differ slightly from current guidelines; always verify with updated references.